B-type Natriuretic Peptide Is a Sensitive Screening Test for Acute Rejection in Pediatric Heart Transplant Patients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 6, 2008, Pages 649-654

  Rossano, Joseph W ^a   Denfield, Susan W ^a   Kim, Jeffrey J ^a   Price, Jack F ^a   Jefferies, John L ^a   Decker, Jamie A ^a   Smith, E O 'Brian ^a   Clunie, Sarah K ^a   Towbin, Jeffrey A ^a   Dreyer, William J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CONFIDENCE INTERVAL; EVALUATION; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; ROC CURVE; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BIOPSY, NEEDLE; CHILD; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MASS SCREENING; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 43949117393     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.03.008     Document Type: Article

References (41)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
2. White J.A., Guiraudon C., Pflugfelder P.W., and Kostuk W.J. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 14 (1995) 1052-1056
3. Heimansohn D.A., Robison R.J., Paris III J.M., et al. Routine surveillance endomyocardial biopsy: late rejection after heart transplantation. Ann Thorac Surg 64 (1997) 1231-1236
4. Boucek M.M., Waltz D.A., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 893-903
5. Cowley C.G., Lozier J.S., Orsmond G.S., and Shaddy R.E. Safety of endomyocardial biopsy in children. Cardiol Young 13 (2003) 404-407
6. Sun J.P., Abdalla I.A., Asher C.R., et al. Non-invasive evaluation of orthotopic heart transplant rejection by echocardiography. J Heart Lung Transplant 24 (2005) 160-165
7. Dandel M., Hummel M., Meyer R., et al. Left ventricular dysfunction during cardiac allograft rejection: early diagnosis, relationship to the histological severity grade, and therapeutic implications. Transplant Proc 34 (2002) 2169-2173
8. Boyd S.Y., Mego D.M., Khan N.A., Rubal B.J., and Gilbert T.M. Doppler echocardiography in cardiac transplant patients: allograft rejection and its relationship to diastolic function. J Am Soc Echocardiogr 10 (1997) 526-531
9. Puleo J.A., Aranda J.M., Weston M.W., et al. Noninvasive detection of allograft rejection in heart transplant recipients by use of Doppler tissue imaging. J Heart Lung Transplant 17 (1998) 176-184
10. Palka P., Lange A., Galbraith A., et al. The role of left and right ventricular early diastolic Doppler tissue echocardiographic indices in the evaluation of acute rejection in orthotopic heart transplant. J Am Soc Echocardiogr 18 (2005) 107-115
11. Toumanidis S.T., Papadopoulou E.S., Saridakis N.S., et al. Evaluation of myocardial performance index to predict mild rejection in cardiac transplantation. Clin Cardiol 27 (2004) 352-358
12. Burgess M.I., Bright-Thomas R.J., Yonan N., and Ray S.G. Can the index of myocardial performance be used to detect acute cellular rejection after heart transplantation?. Am J Cardiol 92 (2003) 308-311
13. Leonard Jr. G.T., Fricker F.J., Pruett D., et al. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients. J Heart Lung Transplant 25 (2006) 61-66
14. Mooradian S.J., Goldberg C.S., Crowley D.C., and Ludomirsky A. Evaluation of a noninvasive index of global ventricular function to predict rejection after pediatric cardiac transplantation. Am J Cardiol 86 (2000) 358-360
15. Neuberger S., Vincent R.N., Doelling N., et al. Comparison of quantitative echocardiography with endomyocardial biopsy to define myocardial rejection in pediatric patients after cardiac transplantation. Am J Cardiol 79 (1997) 447-450
16. Loker J., Darragh R., Ensing G., and Caldwell R. Echocardiographic analysis of rejection in the infant heart transplant recipient. J Heart Lung Transplant 13 (1994) 1014-1018
17. Eun L.Y., Gajarski R.J., Graziano J.N., and Ensing G.J. Relation of left ventricular diastolic function as measured by echocardiography and pulmonary capillary wedge pressure to rejection in young patients (≤31 years) after heart transplantation. Am J Cardiol 96 (2005) 857-860
18. Pauliks L.B., Pietra B.A., DeGroff C.G., et al. Non-invasive detection of acute allograft rejection in children by tissue Doppler imaging: myocardial velocities and myocardial acceleration during isovolumic contraction. J Heart Lung Transplant 24 suppl (2005) S239-S248
19. Rosenthal D.N., Chin C., Nishimura K., et al. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. J Heart Lung Transplant 23 (2004) 323-329
20. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
21. O'Neill J.O., McRae III A.T., Troughton R.W., et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416-420
22. Arnau-Vives M.A., Almenar L., Hervas I., et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850-856
23. Almenar L., Hervas I., Martinez-Dolz L., et al. The value of brain natriuretic peptide for the diagnosis of heart transplant rejection. Transplant Proc 34 (2002) 174-175
24. Wu A.H., Johnson M.L., Aaronson K.D., et al. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 24 (2005) 52-57
25. Cuppoletti A., Roig E., Perez-Villa F., et al. Value of NT-proBNP determinations in the follow-up of heart transplantation. Transplant Proc 37 (2005) 4033-4035
26. Hammerer-Lercher A., Mair J., Antretter H., et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant 24 (2005) 1444
27. Martinez-Dolz L., Almenar L., Moro J., et al. Prognostic value of brain natriuretic peptide in heart transplant patients. J Heart Lung Transplant 26 (2007) 986-991
28. Lindblade C.L., Chun D.S., Darragh R.K., et al. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients. Am J Cardiol 95 (2005) 909-911
29. Claudius I., Lan Y.T., Chang R.K., Wetzel G.T., and Alejos J. Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol 92 (2003) 1368-1370
30. Ambrosi P., Oddoze C., Riberi A., et al. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am J Cardiol 94 (2004) 1585-1587
31. Rawlins M.L., Owen W.E., and Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 123 (2005) 439-445
32. Ou C. Personal communication (e-mail), February 15, 2008, Texas Children's Hospital Department of Pathology, Houston, Texas.
33. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
34. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
35. Asante-Korang A., Fickey M., Boucek M.M., and Boucek Jr. R.J. Diastolic performance assessed by tissue Doppler after pediatric heart transplantation. J Heart Lung Transplant 23 (2004) 865-872
36. Ralli S., Horwich T.B., and Fonarow G.C. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J 150 (2005) 1220-1227
37. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 (2003) 571-579
38. Bando M., Ishii Y., Sugiyama Y., and Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93 (1999) 507-514
39. Leuchte H.H., Holzapfel M., Baumgartner R.A., et al. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 128 (2005) 2368-2374
40. Ballester M., Bordes R., Tazelaar H.D., et al. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. J Am Coll Cardiol 31 (1998) 1357-1361
41. Marboe C.C., Billingham M., Eisen H., et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24 suppl (2005) S219-S226